Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Atar

Showing results (101-110 of 405) with videos related to

Pageof 41
Sort By:
American Heart Journal|June 24, 2010
Maximizing scientific knowledge from randomized clinical trialsFinn Gustafsson, Dan Atar, Bertram Pitt, et al.
American Heart Journal|February 20, 2007
Consistent platelet inhibition during long-term maintenance-dose clopidogrel therapy among 359 compliant outpatients with documented vascular diseaseVictor L Serebruany, Alex I Malinin, Dan Atar, et al.
The American Journal of Medicine|January 11, 2005
Prevalence of diastolic dysfunction as a possible cause of dyspnea in the elderlyFrants Pedersen, Ilan Raymond, Jesper Mehlsen, et al.
Journal of Cardiac Failure|August 17, 2004
How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?Morten Svensson, Finn Gustafsson, Søren Galatius, et al.
Acta Neurologica Scandinavica|February 11, 2022
Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelinesBarbara Ratajczak-Tretel, Anna Tancin Lambert, Dan Atar, et al.
Saudi Journal of Medicine & Medical Sciences|October 30, 2025
Integrative Perspectives on Atherosclerosis: From Molecular Mechanisms to Therapeutic ApproachesJamilah S Alrahimi, Fatima A Ahmed, Ali A Haneef, et al.
Thrombosis Research|April 27, 2024
Platelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic steroids compared to strength-trained athletesTea Sætereng Fyksen, Ingebjørg Seljeflot, Paul Vanberg, et al.
Cardiorenal Medicine|June 15, 2017
Spironolactone Treatment and Effect on Survival in Chronic Heart Failure Patients with Reduced Renal Function: A Propensity-Matched StudyViera Stubnova, Ingrid Os, Morten Grundtvig, et al.
The Israel Medical Association Journal : IMAJ|September 24, 2015
Cauda Equina Syndrome in a 36 Week Gravida PatientAlex Geftler, Abraham Sasson, Ilan Shelef, et al.
Cardiology|August 9, 2018
In Current Clinical Practice, after Percutaneous Coronary Intervention for Acute Myocardial Infarction, Are β-Blockers Prescribed for Heart Failure or as Secondary Prevention? A Pilot StudyVidar Ruddox, Jan Erik Otterstad, Dan Atar, et al.
Pageof 41

Showing results (101-110 of 405) with videos related to

Sort By:
Pageof 41
American Heart Journal|June 24, 2010
Maximizing scientific knowledge from randomized clinical trialsFinn Gustafsson, Dan Atar, Bertram Pitt, et al.
American Heart Journal|February 20, 2007
Consistent platelet inhibition during long-term maintenance-dose clopidogrel therapy among 359 compliant outpatients with documented vascular diseaseVictor L Serebruany, Alex I Malinin, Dan Atar, et al.
The American Journal of Medicine|January 11, 2005
Prevalence of diastolic dysfunction as a possible cause of dyspnea in the elderlyFrants Pedersen, Ilan Raymond, Jesper Mehlsen, et al.
Journal of Cardiac Failure|August 17, 2004
How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?Morten Svensson, Finn Gustafsson, Søren Galatius, et al.
Acta Neurologica Scandinavica|February 11, 2022
Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelinesBarbara Ratajczak-Tretel, Anna Tancin Lambert, Dan Atar, et al.
Saudi Journal of Medicine & Medical Sciences|October 30, 2025
Integrative Perspectives on Atherosclerosis: From Molecular Mechanisms to Therapeutic ApproachesJamilah S Alrahimi, Fatima A Ahmed, Ali A Haneef, et al.
Thrombosis Research|April 27, 2024
Platelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic steroids compared to strength-trained athletesTea Sætereng Fyksen, Ingebjørg Seljeflot, Paul Vanberg, et al.
Cardiorenal Medicine|June 15, 2017
Spironolactone Treatment and Effect on Survival in Chronic Heart Failure Patients with Reduced Renal Function: A Propensity-Matched StudyViera Stubnova, Ingrid Os, Morten Grundtvig, et al.
The Israel Medical Association Journal : IMAJ|September 24, 2015
Cauda Equina Syndrome in a 36 Week Gravida PatientAlex Geftler, Abraham Sasson, Ilan Shelef, et al.
Cardiology|August 9, 2018
In Current Clinical Practice, after Percutaneous Coronary Intervention for Acute Myocardial Infarction, Are β-Blockers Prescribed for Heart Failure or as Secondary Prevention? A Pilot StudyVidar Ruddox, Jan Erik Otterstad, Dan Atar, et al.
Pageof 41